Skip to main content
. 2009 Jan 20;9:5. doi: 10.1186/1471-230X-9-5

Table 1.

Demographic characteristics of treated patients (N = 400).

Characteristics Genotype 1
(N = 70)
Genotype 2
(N = 33)
Genotype 3
(N = 260)
Other Genotypes
(N = 6) *
Mixed Genotypes
(N = 31)
Sex-No. (%)
Male 47 (67.1) 22 (66.7) 185 (71.2) 6 [100] 20 (64.5)
Female 23 (32.9) 11 (33.3) 75 (28.8) 0 [0] 11 (35.5)

Age range-years
Mean age (Y) 25–70 21–68 18–55 20–57 21–60
± SD 50 ± 9.5 48 ± 9.0 45 ± 10.2 49 ± 9.8 46 ± 8.4

Ethnic group-No. (%)
Panjabi 50 (71.4) 21 (63.6) 203 (78.1) 4 (66.7) 21 (67.7)
Pashtoons 15 (21.4) 10 (30.3) 41 (15.8) 2 (33.3) 10 (32.3)
Balochi 3 (4.2) 1 (3.0) 7 (2.7) 0 0
Sindhi 2 (2.9) 1 (3.0) 9 (3.4) 0 0

Pre-treatment HCV RNA level
< 200,000 IU/mL 22 (31.4%) 11 (33.3) 71 (27.3) 1 (16.7) 4 (12.9)
> 200,000 IU/mL 48 (68.6) 22 (66.7) 189 (72.7) 5 (83.3) 27 (87.1)

Cirrhosis-No (%)
Present 3 (4.3) 2 (6.1) 9 (3.5) 0 [0] 2 (6.5)
Absent/unknown 67 (95.7) 31 (93.9) 251 (96.5) 6 [100] 29 (93.5)

*Of the patients with other genotypes, 4 had HCV genotype 4 and one each was with genotype 5a and 6a.

Out of 31 patients with mixed genotypes, 13 were with genotypes 3a+3b; 4 with 2a+3b; 3 each with 2a+3a & 1a+1b, 2 each with 1a+3a & 3a+4; 1 each with 1a+3c, 1b+2a, 1c+3b & 1c+3c.

SD, standard deviation.